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Abstract 
MicroRNAs (miRNAs) are small, noncoding RNAs that post-transcriptionally regulate gene 
expression and are recognized for their roles both as modulators of disease progression and as 
biomarkers of disease activity, including neurological diseases, cancer, and cardiovascular disease 
(CVD). Commonly, miRNA abundance is assessed using quantitative real-time PCR (qRT-PCR), 
however, qRT-PCR for miRNA can be labor intensive, time consuming, and may lack specificity for 
detection of mature versus precursor forms of miRNA. Here, we describe a novel double 
molecular beacon approach to miRNA assessment that can distinguish and quantify mature versus 
precursor forms of miRNA in a single assay, an essential feature for use of miRNAs as biomarkers 
for disease. Using this approach, we found that molecular beacons with DNA or combined locked 
nucleic acid (LNA)-DNA backbones can detect mature and precursor miRNAs (pre-miRNAs) of 
low (< 1 nM) abundance in vitro. The double molecular beacon assay was accurate in assessing 
miRNA abundance in a sample containing a mixed population of mature and precursor miRNAs. In 
contrast, qRT-PCR and the single molecular beacon assay overestimated miRNA abundance. 
Additionally, the double molecular beacon assay was less labor intensive than traditional qRT-PCR 
and had 10-25% increased specificity. Our data suggest that the double molecular beacon-based 
approach is more precise and specific than previous methods, and has the promise of being the 
standard for assessing miRNA levels in biological samples. 
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Introduction 
MicroRNAs (miRNAs) are short (~19-23 
nucleotides), conserved, non-coding RNAs that 
repress translation or induce degradation of specific 
messenger RNAs (mRNAs) [1-3]. MiRNAs have been 
identified across every plant and animal species and 
have been shown to regulate a multitude of cellular 
processes. MiRNA biogenesis begins in the nucleus 
where primary miRNA transcripts (pri-miRNAs) are 
generated from various genomic loci [4] by RNA 
polymerase II and III [5]. Subsequently, the 
Microprocessor complex, consisting of the RNase II 
enzyme, Drosha, and its cofactor DGCR8 (DiGeorge 
Syndrome Critical Region 8), cleaves the pri-miRNA. 
The resulting product is a pre-miRNA, which varies 
in length between 60-70 nucleotides. The pre-miRNA 
has a stem-loop hairpin structure that consists of a 
double stranded stem (approximately 33 nucleotides) 
and a single stranded loop [6]. Pre-miRNA is exported 
from the nucleus to the cytoplasm by 
Exportin-5-Ran-GTP where a second RNase, Dicer, 
cleaves the pre-miRNA terminal loop to produce a 
transient double stranded miRNA. The two strands 
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separate into two complimentary mature miRNAs 
(5’-3’ and 3’-5’) [7], either of which may become 
complexed with the RNA-induced silencing complex 
(RISC). Importantly, through variations in miRNA 
processing, a single miRNA genomic locus can 
generate multiple mature miRNAs that differ by only 
a few nucleotides; these variants are known as 
isomiRs (miRNA isoforms). miRNAs guide the RISC 
to specific mRNA targets through base pairing of the 
miRNA seed sequence, defined as nucleotides 2-8 of 
the 5’ end, with the complementary sequence in the 
target mRNA. This interaction can either inhibit target 
mRNA translation or induce its degradation [8]. Since 
miRNA-mediated gene suppression typically requires 
only seven to eight nucleotides, a single miRNA can 
regulate the expression of hundreds of mRNAs [9] 
and many different miRNAs can regulate a single 
mRNA [10]. 
The discovery of miRNAs and their function has 
enhanced our understanding of the complexity of 
gene regulation in health and disease. Physiologic 
concentrations of mature and precursor forms of 
miRNA vary depending on species, tissue, cell type 
and disease state with ranges from nanomolar to 
fetamolar concentrations [11]. To date, a multitude of 
different techniques have been used to detect and 
quantitate miRNA, including northern blotting, 
qRT-PCR, miRNA microarrays, next generation 
sequencing, and molecular beacons. Each quantitative 
method has advantages and disadvantages. Northern 
blotting is the oldest of these techniques but it has low 
throughput, it is time consuming and requires large 
quantities of RNA (8 μg or more) [4]. Most northern 
blotting techniques are less sensitive than newer 
miRNA detection methods; approximately 100,000 
copies of RNA sequence are required for detection by 
blot hybridization compared to a single copy of RNA 
needed in other methods. In addition, northern 
blotting does not multiplex well. qRT-PCR is 
currently the standard for quantitating miRNA. It is 
simple and typically very specific and sensitive. 
However, qRT-PCR often lacks the ability to 
distinguish isomiRs unless the qRT-PCR protocol is 
altered, thereby increasing its cost and making it less 
time-efficient [12, 13]. Microarrays have emerged as a 
high throughput, comprehensive option for 
quantitating miRNA, but they are expensive and have 
limitations in sensitivity and specificity. Also, 
microarray data still need to be validated by other 
methods such as qRT-PCR or northern blot. Next 
generation deep sequencing (NGS) is a highly 
sensitive and specific method for miRNA 
quantification. Using current technology, NGS is able 
to generate high quality data from as little as 10 ng of 
miRNA. However, NGS is expensive and requires a 
significant amount of bioinformatics and biostatistical 
support. As with miRNA microarrays, NGS results 
should be validated by northern or qRT-PCR analysis. 
Therefore, there is a need for new miRNA detection 
and quantification assays that are dynamic, sensitive 
and specific, but also time- and cost-efficient. 
Molecular beacons (MBs) have shown to have these 
features. 
Molecular beacons are single stranded 
oligonucleotide (DNA or RNA) probes labeled with a 
reporter fluorophore at one end and a quencher at the 
other end [14]. In the absence of a complementary 
target nucleic acid sequence, they form a stem-loop 
hairpin structure that results in quenching of the 
fluorophore’s fluorescence [14-16]. Hybridization of 
the molecular beacon’s loop sequence with target 
nucleic acid opens the hairpin and physically 
separates the fluorophore from quencher, allowing a 
fluorescence signal to be emitted upon excitation, 
which can be assessed in a standard fluorescence plate 
reader (Figure 1). For detection of a mature miRNA, 
the molecular beacon hybridizes to matching 
nucleotides in the mature miRNA. The detection of 
the pre-miRNA occurs when the pre-miRNA 
molecular beacon hybridizes to the loop sequence of 
the pre-miRNA stem-loop complex. In theory, the 
molecular beacon elicits a signal only upon direct 
hybridization to the complementary RNA sequence. 
This enables a molecular beacon to function as a 
sensitive and specific probe with a better 
signal-to-background noise ratio [17-24]. In addition, 
RNA abundance is directly correlated to molecular 
beacon fluorescence. 
The mature miRNA sequence is also present in 
its pri-miRNA and pre-miRNA forms. Therefore, 
methods that are not able to readily distinguish 
between mature and precursor forms of miRNA, such 
as qRT-PCR and miRNA microarray, may report 
falsely high values for miRNA abundance in samples 
that contain a mixture of different miRNA forms. This 
is a particular problem for low abundance miRNAs. 
Furthermore, the ability to distinguish between 
mature and precursor forms of miRNA is important 
for studies that examine regulation of miRNA 
processing. Our group recently demonstrated that 
molecular beacons can readily distinguish mature and 
precursor miRNA and reliably quantify their 
expression in the same sample. In contrast to 
qRT-PCR and microarrays, molecular beacons can 
also distinguish between different isomiRs of a 
consensus miRNA as well as between miRNA family 
members that have similar sequences [25]. Intrinsic 
limitations in molecular beacon affinity for target 
miRNA can be overcome by the incorporation of LNA 
backbone chemistry into molecular beacon design. 
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Here, we describe a novel molecular beacon-based 
assay that overcomes limitations in molecular beacon 
specificity for mature and precursor forms of miRNA. 
We demonstrate that quantitation of multiple mature 
miRNAs and pre-miRNAs in a single sample can be 
accomplished through multiplex assays with 
molecular beacons that target different miRNA forms 
and contain fluorophores with non-overlapping 
spectra.  
 
 
Figure 1. Schematics of Molecular Beacon Hybridization to target mature and precursor miRNA. In the absence of complementary target, molecular beacons 
form a stem–loop structure that brings the quencher in close proximity to the fluorophore, thereby quenching the fluorescence emission. Hybridization of the molecular beacons 
to its target mature or precursor miRNA opens the molecular beacon hairpin, thereby leading to physical separation of the fluorophore from the quencher and allowing 
fluorescence to be measured upon excitation. (A) Hybridization of molecular beacons to the mature miRNA target sequence and unintended hybridization of the mature 
molecular beacon to pre-miRNA. (B) Hybridization of pre-miRNA molecular beacons to the pre-miRNA loop sequence. Also depicted is the inability for mature miRNA to 
hybridize to the pre-miRNA molecular beacon, though 2-3 nucleotide bases from the pre-miRNA molecular beacon may hybridize to the mature miRNA. However, in this latter 
example there is not enough hybridization to separate the quencher from the fluorophore. The use of LNA bases allows the pre-miRNA molecular beacon to have a relatively 
higher affinity for its intended pre-miRNA target then to complementary mature miRNA sequences. 
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Materials and Methods 
Design of miRNA Sequences used in 
Hybridization Assays 
To determine the specificity of the molecular 
beacons, the sequences of wild-type mature miR-21 
and miR-27b, and pre-miR-21 and pre-miR-27b were 
synthesized by Integrated DNA Technologies as 
synthetic miRNA targets. As shown in Table 1, each 
wild-type target also had a complementary 
LNA/DNA sequence designed that was used as a 
blocker in the hybridization assays. Specifically, for 
the mature miR-21 blocker, eight of its 22 nucleotides 
were LNA, while mature miR-27b blocker had six of 
its 20 nucleotides as LNA. Similarly, pre-miR-21 
blocker and pre-miR-27b blocker had six LNA bases 
in each of their sequences. All synthetic nucleotide 
sequences were suspended in nuclease-free water 
(1 nmol/µL) and stored at -80°C. 
Molecular Beacon Design  
DNA or DNA/LNA molecular beacons 
complementary to either the mature consensus 
nucleotide sequence of miR-21/miR-27b or the 
hairpin loop region of the pre-miR-21/pre-miR-27b 
were designed. Molecular beacons targeting mature 
miRNAs, previously described in Baker et al [25] 
contained at least 22 complementary bases, a 6FAM or 
Cy3 fluorophore on the 5’ end, and a Black Hole 
Quencher 1 (BHQ1) or BHQ2 on the 3’ end. 
Additional mature molecular beacons designed to 
target miR-27b that were created specifically for this 
study contained 28 DNA/LNA bases with Cy3 or 
HEX fluorophore on the 5’ end, and a BHQ2 or Dabcyl 
(Dab) on the 3’ end. Similarly, DNA/LNA molecular 
beacons complementary to the loop nucleotide 
sequences of pre-miR-21 and pre-miR-27b were 
designed with 6FAM, Cy3, Hex, or Cy5 fluorophores 
on the 5’ end and BHQ1, BHQ2, Dab or an Iowa Black 
quencher (IAblk) on the 3’ ends. For the LNA 
molecular beacon, a LNA base was placed every third 
nucleotide after the stem (Table 2). All molecular 
beacons were synthesized by Integrated DNA 
Technologies, suspended in nuclease-free water (1 
µg/µL), and stored in an opaque tube and wrapped in 
foil at -80°C. 
 
Table 1: Sequences of mature, precursor miRNA targets and oligo blockers used in molecular beacon hybridization assays. 
Target Name  Sequence (5’-3’)  
Wild-type mature miR-21 UAGCUUAUCAGACUGAUGUUGA  
Wild-type precursor miR-21 UGUCGGGUAGCUUAUCAGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGAUGGGCUGUCUGACA  
Wild-type mature miR-27b UUCACAGUGGCUAAGUUCUGC 
Wild-type precursor miR-27b ACCUCUCUAACAAGGUGCAGAGCUUAGCUGAUUGGUGAACAGUGAUUGGUUUCCGCUUUGUUCACAGUGGCUAA
GUUCUGCACCUGAAGAGAAGGUG  
Oligo Blockers Name  Sequence (5’-3’)  
Mature miR-21 Blocker TCAA+CA+TC+AG+TC+TG+AT+AA+GCTA  
Precursor miR-21 Blocker GCCATGA+GA+TT+CA+AC+AG+TCAACATCAGTC  
Mature miR-27b Blocker GCAGA+AC+TT+AG+CCA+CT+GTGAA  
Precursor miR-27b Blocker AGAACT+TAGCCACTG+TGAACAAAG+CGGAAACCA+ATCACTGTTC+ACCAATCAG+CTAAGC  
Bold = Mature miRNA Blocker and Mature miRNA Molecular Beacon binding sequence; Italics = Precursor miRNA Blocker binding sequence;  
Underline= Precursor miRNA Molecular Beacon binding sequence; + = Locked Nucleic Acid (LNA) Base. 
 
Table 2. Characteristics of Molecular Beacons. 
Probe Names Sequence (5’-3’) Dye Quencher Probe Length Stem Length 
miR21 Mature 1* AGCGTCAACATCAGTCTGATAAGCTACGCT  Cy3 BHQ2 30 5 
miR21 Precursor 1 CGCCATGAGATTCAACAGTCGGCG  FAM BHQ1 24 4 
miR21 Precursor 2 GGTGTTGCCATGAGATTCAAGAGTCAACACC  FAM Dab 30 6 
miR21 Precursor 3* CCTGTTGCC+AT+GA+GA+TT+CA+AC+AG+TCAACAGG  FAM IABLK 30 7 
miR27b Mature 1* CGCAGAACTTAGCCACTGTGAATCTGCG  FAM BHQ1 28 6 
miR27b Mature 2 CGCAGAACTTAGCCACTGTGAATCTGCG  Cy3 BHQ2 28 6 
miR27b Mature 3 CGCAGAACTTAGCCACTGTGAATCTGCG  HEX Dab 28 6 
miR27b Precursor 1* CGGCCAAAGC+GG+AA+AC+CA+AT+CACTGGCCG  Cy3 BHQ2 30 6 
miR27b Precursor 2 CGGCCAAAGC+GG+AA+AC+CA+AT+CACTGGCCG  HEX Dab 30 6 
miR27b Precursor 3 CGGCCAAAGC+GG+AA+AC+CA+AT+CACTGGCCG  Cy5 BHQ1 30 6 
+ = Locked Nucleic Acid (LNA) Base 
Stem Underlined 
BHQ1 = Black Hole Quencher 1; BHQ2 = Black Hole Quencher 2; Cy3 = Cyanine 3; Cy5 = Cyanine 5; Dab = Dabcyl; FAM = (Tetrachloro)fluorescein;  
HEX = Hexachlorofluorescein; IABlk= Iowa Black Quencher. 
 * = Beacon used for Validation 
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RNA Isolation from Endothelial Cells and 
Whole Blood 
Human aortic endothelial cells (HAECs) were 
cultured in EBM-2 media in the presence of 5% CO2 at 
37°C and were used between passages 4-8. RNA from 
the cells was extracted using the miRNeasy kit 
(Qiagen) according to manufacturer’s instructions. 
The miRNA abundance was assessed by the single or 
double molecular beacon assay and qRT-PCR.  
RNA from whole blood was extracted using the 
PAXgene Blood RNA Kit (Qiagen) according to 
manufacturer’s instructions. The miRNA abundance 
was assessed by qRT-PCR and double molecular 
beacon methods.  
Testing of Molecular Beacon Design 
Molecular beacon hybridization to synthetic 
miRNA targets was evaluated in a final volume of 50 
µL containing PBS (pH 7.0) and 200 nM molecular 
beacon. Reactions were performed in a Tecan Safire 
plate reader (384-well flat bottom tray) with 
continuous shaking at 37°C for 60 minutes before the 
intensity of the fluorescence was determined.  
To determine the impact of backbone chemistry 
on molecular beacon sensitivity, verification and 
quantification assays were performed with the 
synthetic targets over a concentration range of 0-5 nM. 
Background signal (molecular beacon without target) 
was subtracted from the fluorescence signal recorded 
for the molecular beacon-miRNA/pre-miRNA 
duplexes. The molecular beacons with the greatest 
sensitivity i.e. the molecular beacon that detected the 
lowest concentration of corresponding targets or 
those molecular beacons previously selected based on 
Baker et al [25] were used in all subsequent 
experiments (Table 2; highlighted molecular 
beacons).  
Mature molecular beacon specificity was tested 
in hybridization assays that included synthetic oligos 
designed to block (oligo blockers, 200 nM; Table 1) 
binding of molecular beacons to their target mature or 
pre-miRNAs. Hybridization conditions (200 nM of 
molecular beacon; 0-100 nM of mixed target miRNA) 
and fluorescence detection methods were similar to 
those described above. The oligo blocker sequences 
shown in Table 1 are comprised of LNA bases and are 
complementary to mature and precursor forms of 
specific miRNAs. The use of DNA/LNA blockers that 
were complementary to mature and precursor forms 
of specific miRNAs allowed for competitive binding 
of the oligo blockers to its target sequence. Thus, 
target sequences that were not bound to blockers 
could subsequently hybridize to a molecular beacon.  
qRT-PCR assays  
For qRT-PCR assessment of miRNA abundance, 
RNA (synthetic - 10 and 50 nM each; cellular - 20-200 
nM; blood –~3 µg/mL) was reverse transcribed using 
the TaqMan MicroRNA Reverse Transcription kit 
(Ambion) as per manufacturer’s instructions. PCR 
was performed using miRNA-specific TaqMan 
MicroRNA Assays (Ambion) and the 
pre-programmed standard curve protocol by 
StepOne™ Real-time PCR System.  
Double Molecular Beacon Assay 
For the double molecular beacon assays, a pair of 
molecular beacons (one mature and one pre-miRNA 
molecular beacon), containing fluorophores with 
non-overlapping spectra, were incubated with a 
sample containing a mixture of complementary target 
mature and pre-miRNA. Hybridization conditions 
(200 nM of molecular beacon; 0-100 nM of mixed 
target miRNA) and fluorescence detection methods 
were similar to those described above.  
When quantitating pre-miRNA and mature 
miRNA abundance using the double molecular 
beacon assay in the whole blood samples, 500 nM of 
molecular beacon was use for hybridization while 
fluorescence detection methods were similar to those 
described above. 
Data analysis and statistics 
For both single and double molecular beacon 
assays, the background fluorescence signal from 
molecular beacon alone was subtracted from the 
fluorescence signal from the duplexes formed by the 
molecular beacon and (pre)miRNA. Paired t-tests 
were used to analyze differences between mature and 
pre-miRNA concentrations that were determined by 
different detection methods (molecular beacon vs. 
qRT-PCR). 
Results 
Design and Testing of Molecular Beacons 
Targeting Mature and Precursor miRNA  
Molecular beacons may be composed of RNA, 
DNA or LNA backbones. It is known that LNA/RNA 
and LNA/DNA complexes have a higher affinity than 
RNA/RNA complexes, DNA/DNA complexes and 
DNA/RNA complexes, respectively [26, 27]. 
Previously, our group showed that molecular beacons 
with LNA bases have the highest affinity for miRNA 
targets [25]. Figures 2A and 2B show the relative 
fluorescence intensity of molecular beacons with 
different backbone chemistries hybridized to mature 
and precursor forms of miR-21 and -27b. For this 
study, all mature miRNA molecular beacons were 
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designed with a DNA backbone, while the 
pre-miRNA molecular beacons are a combination of 
both DNA and LNA/DNA backbones (Table 2). The 
use of LNA/DNA backbone for the pre-miRNA 
molecular beacons was chosen to help increase the 
affinity of the molecular beacon to the target. Using 
the highest affinity backbone for pre-miRNA 
molecular beacon allows it to bind to its targeting 
pre-miRNA despite the predominantly double 
stranded structure. A DNA backbone was used for the 
mature miRNA beacon because, in a sample 
containing both mature and precursor miRNA, the 
lower affinity of the mature molecular beacon is more 
desirable in mixed miRNA populations. For example, 
a molecular beacon targeting mature miRNA may 
bind to sequence in the stem of the precursor miRNA, 
producing an erroneously high fluorescence in a 
mixed population of mature and precursor miRNAs. 
In this scenario, a DNA molecular beacon would be 
less likely to bind to the double stranded stem 
sequence of the pre-miRNA, resulting in less 
unintended hybridization and florescence.  
The molecular beacons containing different 
DNA and LNA/DNA backbones were tested in 
hybridization assays with their respective synthetic 
target miRNAs at low concentrations (0-5 nM). These 
data show that molecular beacons with DNA and 
DNA/LNA backbones can detect target miRNA in 
concentrations as low as 0.5 nM. Only one molecular 
beacon targeting mature miR-21, previously 
characterized by our group, was tested and used [25]. 
However, three mature miRNA molecular beacons 
were tested for miR-27b. The mature miRNA 
molecular beacons for miR-21 and -27b that were 
chosen for subsequent analysis contained DNA bases 
only. Specifically, mature molecular beacon miR-21 
was 30 bases long and its stem consisted of 5 bases (10 
bases total), while the mature molecular beacon 
chosen for miR-27b was 28 bases long with a stem of 6 
bases (12 bases total). Additionally, three pre-miRNA 
DNA and DNA/LNA molecular beacons were 
assessed for their binding to their respective targets 
(pre-miR-21 and -27b). The pre-miRNA molecular 
beacons chosen for subsequent analysis of pre-miR-21 
and -27b both contained LNA bases. For pre-miR-21, 
precursor molecular beacon 3, which had a total of 
eight LNA bases in its backbone, demonstrated the 
best signal to noise ratio. In contrast, precursor miR-21 
molecular beacon 1 and 2, contained no LNA bases 
and did not achieve a signal to noise ratio that 
distinctly distinguished the hybridized beacon from 
non-hybridized beacon. For pre-miR-27b, precursor 
molecular beacon 1 was determined to be the best 
candidate. This molecular beacon contained six LNA 
bases and had a better signal to noise ratio, compared 
to the other molecular beacons designed for 
pre-miR-27b. 
Beacon Specificity: Using Oligo Blockers  
To determine the specificity of molecular 
beacons designed to target mature and precursor 
miR-21 or -27b, molecular beacon hybridization 
assays were performed with the addition of 
competitive oligo blockers. Figure 3A and 3B 
demonstrates that mature miRNA molecular beacons 
targeting mature miR-21 and -27b had low 
fluorescence signal when co-incubated with oligos 
that were anti-sense to the mature miRNA sequence 
(mature miRNA blocker). However, both of these 
mature miRNA molecular beacons hybridized well to 
their synthetic targets when no blockers were present 
or when the pre-miRNA oligo blockers were present. 
 
Figure 2. Determining Molecular Beacon Sensitivity for each Target. Differences in hybridization of molecular beacons to target miRNA with varying backbones 
consisting of DNA and LNA/DNA bases. Molecular beacons (200 nM) were incubated with each synthetic target separately (pre-miR-21 or miR-21 [A] and pre-miR-27b or 
miR-27b [B] [0–5 nM]) in PBS at 37°C for 60 min prior to recording the fluorescence intensity; three pre-miRNA LNA/DNA molecular beacons were designed and tested while 
previously verified mature miRNA DNA molecular beacons were tested for sensitivity only. For each experiment, background fluorescence was subtracted from signal 
produced by hybridization of the molecular beacon to its target miRNA. 
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It should be noted that, in a mixed population of 
mature and precursor targets, the mature miRNA 
molecular beacon has the potential to produce a 
falsely high signal due to its ability to hybridize to the 
mature miRNA sequence within pre-miRNA targets. 
Therefore, the addition of a pre-miRNA blocker with 
the mature molecular beacon in an assay containing a 
mixture of miRNA targets is a more accurate 
representation of the mature molecular beacon 
binding.  
Additionally, these data also reveal the 
differences in the affinity of each molecular beacons 
for their targets. Specifically, in samples with mixed 
miRNA populations that contained mostly 
pre-miRNA, the mature miR-27b molecular beacon 
produced fluorescence signal, despite the presence of 
a pre-miRNA blocker. Although the fluorescence 
signal is mitigated by the presence of the pre-miRNA 
molecular blocker, additional strategies, such as 
utilizing a standard concentration curve, may be 
needed to ensure accurate quantification of the 
mature miRNA only by the mature miR-27b 
molecular beacon.  
In the supplementary data (Figure S1 A and B), 
pre-miR-21 and -27b molecular beacons, respectively, 
showed very high fluorescence signal (indicating 
hybridization of molecular beacon to target) when 
incubated with varying concentrations (0-200nM) of 
synthetic target miRNA. As expected, the 
fluorescence signal of the molecular beacons targeting 
each pre-miRNA was not significantly decreased 
when oligos complementary to the mature miRNA 
sequences (mature miRNA blockers) were included in 
the hybridization assay. In contrast, oligos anti-sense 
to the pre-miRNA sequences (pre-miRNA blockers) 
dramatically inhibited hybridization and resultant 
fluorescence from molecular beacons targeting 
pre-miRNA. 
Double Molecular Beacon Assay  
The results of the previous experiment suggest 
that the specificity of molecular beacons targeting 
mature miRNA is enhanced in the presence of 
precursor miRNA blockers. We hypothesized that 
incubation of both mature and precursor molecular 
beacons with a mixed population of miRNA would 
enable simultaneous measurement of both mature 
and precursor miRNA targets while enhancing 
specificity of the assay. Figure 4A and B shows the 
results of the “Double Molecular Beacon Assay”, 
where concentrations of synthetic mature and 
precursor miRNA targets were varied from 0-200nM.  
 
 
 
Figure 3. Molecular Beacon Hybridization to Targets in Presence of Oligo Blockers. The molecular beacons were designed to hybridize mature miRNA targets. The 
presence of oligo blockers (complementary or competitive) demonstrated the specificity of each molecular beacon. Mature miRNA molecular beacons targeting miR-21(A) and 
-27b (B) were incubated with mixtures of synthetic mature and pre-miRNA at varying concentrations (0-200nM). The design of each mature miRNA molecular beacon allowed 
for the unintended hybridization to precursor miRNA. Therefore, the presence of a mature miRNA blocker inhibited signal from the molecular beacon while the presence of 
pre-miRNA blocker showed a modest change in fluorescence intensity. Each bar represents mean ± SE of 3-6 separate experiments. 
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Figure 4. Double Molecular Beacon Assay. Hybridization of molecular beacons to mature or precursor miRNA. The mature miRNA molecular beacon (200 nM) 
and pre-miRNA molecular beacon (200 nM) (A: miR-21; B: miR-27b) were incubated with mixtures of mature and pre-miRNA targets at the indicated concentrations (60 min 
at 37°C). The relative fluorescence signal from each molecular beacon alone in PBS was used as a background measurement and subtracted from the sample signal. Each data point 
represents mean ± SEM of three separate experiments. 
 
 
The specificity of the double molecular beacon 
assay compared to other methods (single molecular 
beacon and qRT-PCR) was assessed. Equimolar 
mixtures of synthetic mature and precursor miRNA 
(10 nM and 50 nM) were quantitated using qRT-PCR, 
the single molecular beacon assay, and the double 
molecular beacon assay. As shown in Figure 5A 
(10nM) and B (50 nM), the double molecular beacon 
assay was 87.5% accurate in assessing mature and 
precursor miRNA values. On the other hand, the 
single molecular beacon overestimated the mature 
miRNA levels for miR-21 and -27b while the qRT-PCR 
consistently overestimated the mature and precursor 
miRNA levels for miR-21 and -27b. These data 
validate the ability of the double molecular beacon 
assay to accurately quantify mature and precursor 
miRNA in a mixed population at different 
concentrations. Furthermore, the data indicate the 
double beacon assay has greater specificity compared 
to qRT-PCR and single molecular beacon methods.  
Additionally, the sensitivity and specificity of 
the double molecular beacon method to quantify 
mature miRNA and pre-miRNA from biological 
samples was tested. Our previous studies have 
demonstrated the use of the single molecular beacon 
method to quantitate cellular pre-miRNA and mature 
miRNA [25]. Figure 6 displays the quantitation of 
cellular pre-miRNA and mature miRNA using the 
novel double molecular beacon compared to 
qRT-PCR. RNA was isolated from human aortic 
endothelial cells (HAECs) and standard concentration 
curves were used to determine exact concentrations 
for both double molecular beacon and qRT-PCR. 
Mature and precursor miRNA concentrations 
obtained using qRT-PCR and the double molecular 
beacon assay are listed in Figure 6C. These findings 
are aligned with our previous studies of 
pre-miRNA/miRNA ratio [28] and are also supported 
by Lee et al. which indicates the ratio of mature to 
precursor miRNA varies by miRNA and between 
different tissues and cells[29]. In addition, this 
experiment supports the validity of using the double 
molecular beacon-based method to simultaneously 
assess precursor and mature miRNA expression in 
cells and tissues. 
Lastly, the clinical relevance of the double 
molecular beacon method for simultaneously 
quantitation of pre-miRNA and mature miRNA in a 
complex biological matrix was tested. We incubated 
the mature miR-21 molecular beacon and the 
pre-miR-21 molecular beacon with total RNA that had 
been isolated from whole blood. Figure 7A shows the 
fluorescent signals from hybridization assays using 
the miR-21 double molecular beacon method 
compared to single qRT-PCR assays. Mature and 
precursor miRNA concentrations obtained using 
qRT-PCR and the double molecular beacon assay are 
listed in Figure 7B. This assay needs to be repeated 
with molecular beacons targeting other miRNAs, but 
these results support the use of this method in clinical 
samples as it is more time-efficient and as specific as 
the gold-standard qRT-PCR. 
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Figure 5. Comparison of Double Molecular Beacon Assay to qRT PCR and Single Molecular Beacon Assay. Comparison of double molecular beacon assay with 
qRT–PCR and single molecular beacon assay in simultaneously measurement of mature and precursor miRNAs. Assays were performed on solutions containing mixed, equimolar 
concentrations (A. 10 nM and B. 50 nM) of mature and precursor forms of miR-21 and miR-27b. For single and double MB assays, background fluorescence was subtracted from 
hybridized beacon signal. For qRT-PCR standard TaqMan protocol was followed. Standard concentration curves were used to determine concentration in all methods. Each data 
point represents mean ± SD of six separate experiments. Tables display the numerical concentrations and the P-values (paired t-tests P > 0.05) (significance indicated in red). 
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Figure 6. Comparison of qRT-PCR and Double Molecular Beacon Assay in assessing mature and precursor miRNA levels in total cellular RNA. Comparison 
of qRT–PCR and double molecular beacon assay in assessing miRNA concentrations in total RNA isolated from HAECs. MiRNA levels (A. miR-21 and B. miR-27b) in total RNA 
extracted from HAECs was determined. For each qRT–PCR reaction, the standard TaqMan protocol was used using 1 µg of total RNA. For the double molecular beacon 
hybridization assays, 200 nM of each molecular beacon and 1 µg of total RNA were used. Standard concentration curves were used to determine concentration in both methods. 
Additionally, for the double molecular beacon assay background fluorescence was subtracted from beacon signal. Each data point represents Mean ± SD of six separate 
experiments. C. Table displaying the numerical concentrations and the p-values (paired t-tests). (P > 0.05). 
 
Discussion 
In this study, we demonstrated that the double 
molecular beacon assay could distinguish between 
mature miRNA and pre-miRNA species as well as 
effectively and efficiently assess miRNA levels in a 
sample containing a mixture of mature and precursor 
forms of miRNA. This assay has the potential to be a 
powerful tool for quantifying miRNA expression in 
clinical specimens. Specifically, we showed that the 
double molecular beacon assay was effective for 
quantifying different miRNAs forms within a 
concentration range of 0.5-200 nM.  
Backbone chemistry is an important component 
of molecular beacon design and in the double 
molecular beacon assay, the mature and pre-miRNA 
molecular beacons had different backbone 
chemistries. Since targeted pre-miRNA can hybridize 
to both pre-miRNA and mature molecular beacons 
(Figure 1), we developed pre-miRNA molecular 
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beacons that contained LNA bases, thereby enhancing 
their binding to pre-miRNA target relative to the 
mature molecular beacon, which contained a DNA 
backbone without LNA bases. Additionally, the LNA 
bases in the pre-miRNA molecular beacon should 
reduce steric hindrance by stabilizing the hairpin 
pre-miRNA target; and can also be useful in future 
applications as LNA designed beacons have the 
ability to distinguish between single nucleotide 
differences within the mature miRNA and 
pre-miRNA sequences.  
In addition, in samples containing a mixture of 
mature and precursor miRNAs, we did observe that 
the affinity of the mature molecular beacon with a 
DNA backbone was strong enough to bind when the 
complementary mature miRNA was present, 
however, the mature miRNA molecular beacon did 
not “lock” or create as tight of a bond with the much 
longer pre-miRNA targets. This is evidenced by 
decreased mature miRNA molecular beacon signal 
when incubated with pre-miRNA blocker or 
pre-miRNA beacon in samples containing 
predominantly pre-miRNA target (Figure 3 and 
Figure 4). Furthermore, the pre-miRNA blockers/ 
pre-miRNA molecular beacons contained LNA/DNA 
bases that allowed them to competitively bind to the 
pre-miRNA in the sample and facilitate the binding of 
the mature miRNA molecular beacon only to mature 
miRNA target (instead of to both the mature and 
precursor miRNA target). This finding led to 
development of the innovated double molecular 
beacon assay for measurement of mature miRNA and 
subsequently pre-miRNA in a sample containing a 
mixed population of miRNA targets.  
The important features of the double molecular 
beacon assay are: i) the usage of mature and 
pre-miRNA molecular beacons with different 
backbone chemistries and target binding affinities; 
and ii) the complementary blocking of the pre-miRNA 
target by the precursor miRNA molecular beacon and 
the intentional binding of the mature miRNA 
molecular beacon to the mature miRNA targets. These 
features were essential for attenuating falsely high 
background signal related to the binding of the 
mature miRNA molecular beacon to the target 
sequence in the stem of the pre-miRNA target during 
the double beacon assay (Figure 1A).  
Again, in the double molecular beacon assay, a 
pre-miRNA molecular beacon is used to block the 
unintended hybridization of pre-miRNA target to 
mature molecular beacon (Figure 4), thereby allowing 
for accurate measurement of different miRNA forms 
in a mixed population. In contrast, we found that 
qRT-PCR and the single molecular beacon assay both 
overestimated miRNA levels in samples containing 
mixed miRNA populations. For qRT-PCR, this is 
 
Figure 7. Comparison of qRT-PCR and Double Molecular Beacon Assay in assessing mature and precursor miRNA levels in whole blood RNA. 
Comparison of qRT–PCR and double molecular beacon assay in assessing miR-21 concentrations in total RNA isolated from whole blood (obtained from healthy volunteer). 
MiRNA levels (A. miR-21) in total RNA extracted from whole blood was determined. For each qRT–PCR reaction, the standard TaqMan protocol was used with 3 µg of total 
RNA. For the double molecular beacon hybridization assays, 500 nM of each molecular beacon and 3 µg of total RNA were used. Standard concentration curves were used to 
determine concentration in both methods. Additionally, for the double molecular beacon assay background fluorescence was subtracted from beacon signal. Each data point 
represents Mean ± SD of six separate experiments. B. Table displaying the numerical concentrations and the p-values (paired t-tests) (P > 0.05). 
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likely due to nonspecific binding of the RT primers to 
the mature and pre-miRNA targets, allowing for 
nonspecific reverse transcription and amplification of 
RT products by PCR primers [30, 31]. For a single 
molecular beacon, the overestimation was observed 
when measuring mature miRNA in a mixed miRNA 
population and was caused by the unintended 
binding of the pre-miRNA to the mature miRNA 
molecular beacon with DNA backbone. As pointed 
out earlier, we found that the presence of pre-miRNA 
blockers enhanced the specificity of the mature 
molecular beacons for their targets during a single 
molecular beacon assay (Figure 3). Thus, 
unintentional binding in the single molecular beacon 
assay and the nonspecific binding and broad 
amplification of miRNAs seen when performing 
qRT-PCR resulted in a quantifiable overestimation of 
both pre-miRNA and mature miRNA. 
The double molecular beacon assay does have 
certain shortcomings. When performing the double 
molecular beacon assay on synthetic miRNA targets 
(Figure 5), we found that the double beacon assay also 
tended to overestimate miRNA levels, although this 
was significantly less than qRT-PCR and the single 
molecular beacon assay. Overestimation of miRNA 
levels by the double molecular beacon assay was also 
less pronounced in assays using cellular RNA or RNA 
from whole blood (Figure 6 and Figure 7). 
Overestimation by the double molecular beacon assay 
is likely caused by unintentional hybridization of 
pre-miRNA to mature molecular beacon at high 
concentrations and was exacerbated when 
quantitating miRNA in samples containing synthetic 
targets due to the purity of the targets in these 
samples. In addition, it should be noted that some 
molecular beacons have higher background signal, as 
observed with mature and pre-miRNA 27b molecular 
beacons (Figure 4B). To correct for this high 
background signal, double molecular beacon data 
should be reported as relative fluorescence or by 
using a standard curve and reporting miRNA 
concentration levels. Lastly, in this study, we have 
validated the use of the double molecular beacon 
assay for both miR-21 and -27b, but additional 
optimization experiments will be required for 
developing double molecular beacon assays for other 
miRNAs.  
The use of the double molecular beacon assay to 
quantitate miRNA is preferable to other methods 
because it can accurately assess differences in miRNA 
levels within mixed populations. The hybridization of 
molecular beacons to target miRNA and the 
measurement of fluorescence can be performed 
relatively quickly, in approximately 20–30 min, which 
is one-third the time of traditional qRT-PCR. Other 
conventional methods for miRNA detection, such as 
Northern Blotting, microarrays, and NGS, are able to 
quantitate miRNA expression in the fetamolar range, 
but they all have lower specificity with higher cost. 
These conventional methods also have not been 
thoroughly assessed for their ability to successfully 
multiplex for both mature and precursor forms of a 
miRNA while maintaining their sensitivity, 
specificity, time effectiveness, and cost [32].  
In addition to the novelty of this method, it is 
also versatile. We demonstrated that this method can 
successful quantitate pre-miRNA and mature miRNA 
from synthetic targets, RNA isolated from cells 
(Figure 6) and even RNA isolated from whole blood 
(Figure 7). This versatility indicates that the method 
can not only be used as a laboratory research tool but 
also as a potential clinical tool. 
Overall, the double molecular beacon assay is 
highly specific when detecting both mature and 
precursor forms of miRNA in a biological sample. 
Potential other applications of a double molecular 
beacon assay are quantitation of miRNA variants, 
such as isomiRs, which vary from the archetypal 
miRNA by 1-3 nucleotides. The advantage of 
quantitating isomiRs using molecular beacons lies in 
their ability to distinguish targets with single 
nucleotide differences and their ability to quantitate 
isomiRs that are expressed at very low concentrations. 
Therefore, this innovative double molecular 
beacon-based miRNA detection offers a hybridization 
assay format that is sensitive, specific, fast, easy to 
multiplex and capable of distinguishing mature and 
pre-miRNAs for both clinical and research use.  
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